This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Chemed Corp (CHE)

NYSE: Health Care

Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 1.41B 1.43B 1.36B 1.28B
Cost of Sales 998.38M 1.02B 961.77M 898.28M
Gross Operating Profit 414.95M 406.09M 394.20M 382.26M
Selling, General, and Administrative Expenses 228.24M 209.78M 202.26M 201.96M
Research & Development 0.00 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 186.71M 196.31M 191.94M 180.30M
Depreciation & Amortization 42.81M 39.89M 38.21M 36.78M
Interest Income 847.00K 809.00K 426.00K 444.00K
Other Income - Net 4.62M 3.31M 291.00K 1.82M
Special Income / Charges -10.50M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 138.86M 160.54M 154.44M 145.79M
Interest Expense 15.04M 14.72M 13.89M 11.96M
Pre-Tax Income 123.83M 145.82M 140.56M 133.83M
Income Taxes 46.60M 56.52M 54.58M 52.00M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 77.23M 89.30M 85.98M 81.83M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 77.23M 89.30M 85.98M 81.83M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 77.23M 89.30M 85.98M 81.83M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
87.73M 89.30M 85.98M 81.83M
Preferred Dividends
Net Income Available To Common 77.23M 89.30M 85.98M 81.83M
Basic EPS from Continuing Ops. 4.24 4.72 4.19 3.62
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 4.24 4.72 4.19 3.62
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 4.24 4.72 4.19 3.62
Basic Normalized Net Income/Share 4.82 4.72 4.19 3.62
EPS fr Continuing Ops. 4.16 4.62 4.10 3.55
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 4.16 4.62 4.10 3.55
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 4.16 4.62 4.10 3.55
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
4.72 4.62 4.10 3.55
Dividends Paid per Share 0.76 0.68 0.60 0.52
CHE News

Analysts Ratings for CHE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CHE ANALYST REPORT

Brokerage Partners

CHE Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs